ChroniSense National Early Warning Score Study (CHESS): a wearable wrist device to measure vital signs in hospitalised patients—protocol and study design

Introduction The National Early Warning Score is used as standard clinical practice in the UK as a track and trigger system to monitor hospitalised patients. Currently, nurses are tasked to take routine vital signs measurements and manually record these on a clinical chart. Wearable devices could pr...

Full description

Saved in:
Bibliographic Details
Main Authors: Michelle Helena van Velthoven, David Brindley, Felicia Adjei, Dimitris Vavoulis, Glenn Wells, Attila Kardos
Format: Article
Language:English
Published: BMJ Publishing Group 2019-09-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/9/9/e028219.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850066603313463296
author Michelle Helena van Velthoven
David Brindley
Felicia Adjei
Dimitris Vavoulis
Glenn Wells
Attila Kardos
author_facet Michelle Helena van Velthoven
David Brindley
Felicia Adjei
Dimitris Vavoulis
Glenn Wells
Attila Kardos
author_sort Michelle Helena van Velthoven
collection DOAJ
description Introduction The National Early Warning Score is used as standard clinical practice in the UK as a track and trigger system to monitor hospitalised patients. Currently, nurses are tasked to take routine vital signs measurements and manually record these on a clinical chart. Wearable devices could provide an easier, reliable, more convenient and cost-effective method of monitoring. Our aim is to evaluate the clinical validity of Polso (ChroniSense Medical, Yokneam Illit, Israel), a wrist-based device, to provide National Early Warning Scores.Methods and analysis We will compare Polso National Early Warning Score measurements to the currently used manual measurements in a UK Teaching District General Hospital. Patients aged 18 years or above who require recordings of observations of vital signs at least every 6 hours will be enrolled after consenting. The sample size for the study was calculated to be 300 participants based on the assumption that the final dataset will include four pairs of measurements per-patient and per-vital sign, resulting in a total of 1200 pairs of data points per vital sign. The primary outcome is the agreement on the individual parameter scores and values of the National Early Warning Score: (1) respiratory rate, (2) oxygen saturation, (3) body temperature, (4) systolic blood pressure and (5) heart rate. Secondary outcomes are the agreement on the aggregate National Early Warning Score. The incidence of adverse events will be recorded. The measurements by the device will not be used for the clinical decision-making in this study.Ethics and dissemination We obtained ethical approval, reference number 18/LO/0123 from London—Hampstead Research Ethics Committee, through the Integrated Research Application System, (reference number: 235 034. The study received no objection from the Medicine and Health Regulatory Authority, reference number: CI/20018/005 and has National Institute for Health Research portfolio adoption status CPMS number: 32 532.Trial registration number NCT03448861; Pre-results.
format Article
id doaj-art-34cd952a4fc249a5ae848717020aac06
institution DOAJ
issn 2044-6055
language English
publishDate 2019-09-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-34cd952a4fc249a5ae848717020aac062025-08-20T02:48:42ZengBMJ Publishing GroupBMJ Open2044-60552019-09-019910.1136/bmjopen-2018-028219ChroniSense National Early Warning Score Study (CHESS): a wearable wrist device to measure vital signs in hospitalised patients—protocol and study designMichelle Helena van Velthoven0David Brindley1Felicia Adjei2Dimitris Vavoulis3Glenn Wells4Attila Kardos51 Department of Paediatrics, University of Oxford, Oxford, UK2 Healthcare Translation Research Group, Department of Paediatrics, University of Oxford, Oxford, UK2 Department of Cardiology, Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes, UK3 Department of Oncology, University of Oxford, Oxford, UK4 Oxford Academic Health Science Centre, Oxford, UK6 Faculty of Life Sciences, University of Buckingham, Buckingham, United KingdomIntroduction The National Early Warning Score is used as standard clinical practice in the UK as a track and trigger system to monitor hospitalised patients. Currently, nurses are tasked to take routine vital signs measurements and manually record these on a clinical chart. Wearable devices could provide an easier, reliable, more convenient and cost-effective method of monitoring. Our aim is to evaluate the clinical validity of Polso (ChroniSense Medical, Yokneam Illit, Israel), a wrist-based device, to provide National Early Warning Scores.Methods and analysis We will compare Polso National Early Warning Score measurements to the currently used manual measurements in a UK Teaching District General Hospital. Patients aged 18 years or above who require recordings of observations of vital signs at least every 6 hours will be enrolled after consenting. The sample size for the study was calculated to be 300 participants based on the assumption that the final dataset will include four pairs of measurements per-patient and per-vital sign, resulting in a total of 1200 pairs of data points per vital sign. The primary outcome is the agreement on the individual parameter scores and values of the National Early Warning Score: (1) respiratory rate, (2) oxygen saturation, (3) body temperature, (4) systolic blood pressure and (5) heart rate. Secondary outcomes are the agreement on the aggregate National Early Warning Score. The incidence of adverse events will be recorded. The measurements by the device will not be used for the clinical decision-making in this study.Ethics and dissemination We obtained ethical approval, reference number 18/LO/0123 from London—Hampstead Research Ethics Committee, through the Integrated Research Application System, (reference number: 235 034. The study received no objection from the Medicine and Health Regulatory Authority, reference number: CI/20018/005 and has National Institute for Health Research portfolio adoption status CPMS number: 32 532.Trial registration number NCT03448861; Pre-results.https://bmjopen.bmj.com/content/9/9/e028219.full
spellingShingle Michelle Helena van Velthoven
David Brindley
Felicia Adjei
Dimitris Vavoulis
Glenn Wells
Attila Kardos
ChroniSense National Early Warning Score Study (CHESS): a wearable wrist device to measure vital signs in hospitalised patients—protocol and study design
BMJ Open
title ChroniSense National Early Warning Score Study (CHESS): a wearable wrist device to measure vital signs in hospitalised patients—protocol and study design
title_full ChroniSense National Early Warning Score Study (CHESS): a wearable wrist device to measure vital signs in hospitalised patients—protocol and study design
title_fullStr ChroniSense National Early Warning Score Study (CHESS): a wearable wrist device to measure vital signs in hospitalised patients—protocol and study design
title_full_unstemmed ChroniSense National Early Warning Score Study (CHESS): a wearable wrist device to measure vital signs in hospitalised patients—protocol and study design
title_short ChroniSense National Early Warning Score Study (CHESS): a wearable wrist device to measure vital signs in hospitalised patients—protocol and study design
title_sort chronisense national early warning score study chess a wearable wrist device to measure vital signs in hospitalised patients protocol and study design
url https://bmjopen.bmj.com/content/9/9/e028219.full
work_keys_str_mv AT michellehelenavanvelthoven chronisensenationalearlywarningscorestudychessawearablewristdevicetomeasurevitalsignsinhospitalisedpatientsprotocolandstudydesign
AT davidbrindley chronisensenationalearlywarningscorestudychessawearablewristdevicetomeasurevitalsignsinhospitalisedpatientsprotocolandstudydesign
AT feliciaadjei chronisensenationalearlywarningscorestudychessawearablewristdevicetomeasurevitalsignsinhospitalisedpatientsprotocolandstudydesign
AT dimitrisvavoulis chronisensenationalearlywarningscorestudychessawearablewristdevicetomeasurevitalsignsinhospitalisedpatientsprotocolandstudydesign
AT glennwells chronisensenationalearlywarningscorestudychessawearablewristdevicetomeasurevitalsignsinhospitalisedpatientsprotocolandstudydesign
AT attilakardos chronisensenationalearlywarningscorestudychessawearablewristdevicetomeasurevitalsignsinhospitalisedpatientsprotocolandstudydesign